Enhabit (EHAB) | Financial Analysis & Statements
Enhabit Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
270.4M
Gross Profit
131.7M
48.71%
Operating Income
14.4M
5.33%
Net Income
-38.3M
-14.16%
EPS (Diluted)
$-0.76
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
603.0M
Shareholders Equity
564.1M
Debt to Equity
1.07
Cash Flow Metrics
Operating Cash Flow
-24.0M
Free Cash Flow
3.3M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Enhabit Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.0B | 1.0B | 1.1B | 1.1B |
| Cost of Goods Sold | 540.2M | 530.8M | 535.6M | 525.6M | 513.9M |
| Gross Profit | 519.8M | 504.0M | 510.7M | 545.5M | 592.7M |
| Gross Margin % | 49.0% | 48.7% | 48.8% | 50.9% | 53.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 433.5M | 425.9M | 441.6M | 414.9M | 412.9M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 433.5M | 425.9M | 441.6M | 414.9M | 412.9M |
| Operating Income | 63.8M | 46.6M | 38.2M | 97.6M | 142.9M |
| Operating Margin % | 6.0% | 4.5% | 3.7% | 9.1% | 12.9% |
| Non-Operating Items | |||||
| Interest Income | 200.0K | - | - | - | - |
| Interest Expense | 34.0M | 42.9M | 43.0M | 15.0M | 300.0K |
| Other Non-Operating Income | -28.6M | -161.7M | -85.6M | -108.1M | 5.4M |
| Pre-tax Income | 1.4M | -158.0M | -90.4M | -25.5M | 148.0M |
| Income Tax | 4.0M | -4.0M | -11.4M | 12.8M | 35.1M |
| Effective Tax Rate % | 285.7% | 0.0% | 0.0% | 0.0% | 23.7% |
| Net Income | -2.6M | -154.0M | -79.0M | -38.3M | 112.9M |
| Net Margin % | -0.2% | -14.9% | -7.6% | -3.6% | 10.2% |
| Key Metrics | |||||
| EBITDA | 105.6M | 78.1M | 69.3M | 131.5M | 185.2M |
| EPS (Basic) | - | $-3.11 | $-1.61 | $1.26 | $2.23 |
| EPS (Diluted) | - | $-3.11 | $-1.61 | $1.26 | $2.23 |
| Basic Shares Outstanding | - | 50200000 | 49900000 | 49600000 | 49898344 |
| Diluted Shares Outstanding | - | 50200000 | 49900000 | 49600000 | 49898344 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Enhabit Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 43.6M | 28.4M | 27.4M | 22.9M | 5.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 144.0M | 149.2M | 164.7M | 149.6M | 164.5M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 16.1M | 13.2M | 12.6M | 23.6M | 6.3M |
| Total Current Assets | 205.6M | 192.7M | 210.1M | 211.8M | 178.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 49.8M | 52.8M | 57.5M | 42.0M | 48.4M |
| Goodwill | 1.7B | 1.9B | 2.2B | 2.4B | 2.6B |
| Intangible Assets | 38.5M | 58.1M | 80.0M | 102.6M | 259.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.4M | 4.7M | 5.3M | 5.2M | 24.3M |
| Total Non-Current Assets | 961.5M | 1.0B | 1.2B | 1.3B | 1.5B |
| Total Assets | 1.2B | 1.2B | 1.4B | 1.5B | 1.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 9.2M | 6.7M | 7.6M | 3.8M | 3.5M |
| Short-term Debt | 34.9M | 35.1M | 34.3M | 37.1M | 19.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 41.8M | 36.4M | 40.7M | 40.7M | 24.8M |
| Total Current Liabilities | 126.3M | 126.2M | 137.7M | 132.9M | 136.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 465.1M | 534.4M | 575.8M | 588.1M | 37.0M |
| Deferred Tax Liabilities | 11.5M | 11.5M | 17.1M | 28.6M | 63.2M |
| Other Non-Current Liabilities | 100.0K | - | 1.3M | 1.9M | - |
| Total Non-Current Liabilities | 476.7M | 545.9M | 594.2M | 618.6M | 100.2M |
| Total Liabilities | 603.0M | 672.1M | 731.9M | 751.5M | 236.7M |
| Equity | |||||
| Common Stock | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K |
| Retained Earnings | 93.7M | 98.3M | 254.5M | 335.0M | 375.4M |
| Treasury Stock | 3.8M | 1.7M | 600.0K | 0 | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 564.1M | 553.9M | 701.7M | 775.3M | 1.5B |
| Key Metrics | |||||
| Total Debt | 500.0M | 569.5M | 610.1M | 625.2M | 56.9M |
| Working Capital | 79.3M | 66.5M | 72.4M | 78.9M | 42.3M |
Balance Sheet Composition
Enhabit Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -2.6M | -154.0M | -79.0M | -38.3M | 112.9M |
| Depreciation & Amortization | 22.5M | 31.5M | 30.9M | 33.0M | 36.9M |
| Stock-Based Compensation | 16.6M | 11.7M | 8.9M | 9.2M | 3.6M |
| Working Capital Changes | 2.4M | 4.3M | -10.4M | 29.3M | -25.0M |
| Operating Cash Flow | 40.8M | -111.3M | -59.5M | 29.6M | 131.4M |
| Investing Activities | |||||
| Capital Expenditures | -4.9M | -3.8M | -3.5M | -7.1M | -4.3M |
| Acquisitions | 0 | 0 | -2.8M | -36.3M | -117.5M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 21.0M | - | - | - | - |
| Investing Cash Flow | 16.7M | -2.4M | -5.3M | -42.3M | -119.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | 0 | 0 | -654.9M | -154.1M |
| Debt Issuance | - | 0 | 0 | 590.0M | 0 |
| Debt Repayment | -67.7M | -43.6M | -33.4M | -15.0M | -7.2M |
| Financing Cash Flow | -72.2M | -48.3M | -40.5M | -18.6M | -36.1M |
| Free Cash Flow | 65.8M | 47.4M | 44.9M | 73.0M | 119.0M |
| Net Change in Cash | -14.7M | -162.0M | -105.3M | -31.3M | -23.9M |
Cash Flow Trend
Enhabit Key Financial Ratios
Valuation Ratios
Forward P/E
22.11
Price to Book
1.30
Price to Sales
0.66
PEG Ratio
22.11
Profitability Ratios
Profit Margin
-0.43%
Operating Margin
5.33%
Return on Equity
-0.47%
Return on Assets
3.33%
Financial Health
Current Ratio
1.63
Debt to Equity
88.64
Beta
1.08
Per Share Data
EPS (TTM)
$-0.09
Book Value per Share
$10.53
Revenue per Share
$20.87
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EHAB | 703.8M | - | 1.30 | -0.47% | -0.43% | 88.64 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






